期刊文献+

白藜芦醇对去卵巢大鼠股骨骨保护素及核因子κB受体活化子配体表达的影响 被引量:3

Effects of resveratrol on the expression of osteoprotegerin and receptor activator for NF-κB ligand in femurs of ovariectomized rats
下载PDF
导出
摘要 目的:观察白藜芦醇对去卵巢大鼠股骨骨保护素(OPG)及核因子κB受体活化子配体(RANKL)表达的影响。方法:健康3月龄雌性SD大鼠48只,按体重随机分为6组:假手术组(SHAM)、单纯卵巢切除组(OVX)、17β-雌二醇组(ERT,0.1mg.kg-1·d-1)。低、中、高剂量白藜芦醇组(RL、RM、RH,每天分别给予10、20、40mg/kg白藜芦醇)。除假手术组外其余各组均切除双侧卵巢。术后1周开始给药,给药8周后处死所有大鼠,测定股骨骨密度(BMD)及骨生物力学性能:弹性模量(ELASTIC)、刚度(STIFFNESS)、最大应力(M-STRESS)及最大承载力(M-LORD)。用免疫组织化学染色方法观察股骨OPG、RANKL的表达。结果:与OVX组比较,20、40mg·kg-1.d-1白藜芦醇均能上调股骨OPG表达(P<0.05)。与OVX组比较,20、40mg.kg-1·d-1白藜芦醇均下调RANKL的表达,改善股骨骨密度及生物力学性能(P<0.05)。结论:白藜芦醇在体内可上调骨组织中OPG的表达,下调RANKL的表达,这可能是其改善股骨骨密度及生物力学性能的作用机制。 AIM: To study effects of resvemtrol on osteoprotegerin(OPG) and receptor activator of NF-κB ligand(RANKL) expression in femur of ovariectomized rats. METHODS: 48 female SD rats (3 months old) were assigned into 6 groups randomly: sham-operated group(SHAM) ; ovariectomized group(OVX) ; 17β-estradiol replacement therapy group ( ERT, 0.1 mg·kg^- 1·d^- 1, sc) ; high-dose resveratrol-treate group (RH, 40 mg·kg^- 1·d^- 1, i.p. ) ; middle-dose resveratrol-treated group ( RM, 20 mg·kg^- 1·d^- 1, i. p. ) ;low-dose resveratrol-treated group ( RL, 10 mg·kg^-1·d^-1, i. p. ). Except for SHAM group, rats in other groups were operated by bilateral ovariectomy. Administration started at the 8th day after operation and lasted 8 weeks. At the end of the 9th week after operation, all rats were sacrificed. The bone mineral density (BMD) and vitodynamics properties( including ELASTIC, M-STRESS, M-LORD and STIFFNESS) of femurs were measured. The expression of OPG and RANKL in femurs of rats were observed by immunohistochemical staining methods. RESULTS: Compared with OVX group, resveratrol treatment ( 40 mg·kg^-1·d^-1 and 20 mg·kg^-1·d^-1 ) increased expression of OPG in femurs while decreased expression of RANKL in ovariectmized rats. In RH, RM, and ERT group, BMD, ELASTIC, M-STRESS of femurs were higher than those of OVX group. CONCLUSION: Resveratrol increased expression of OPG in femur while decreased expression of RANKL in ovariectmized rats, which was probably one of mechanism that resveratrol improve osteoporosis.
作者 王艳 汤旭磊
出处 《中国临床药理学与治疗学》 CAS CSCD 2008年第3期266-270,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 白藜芦醇 骨质疏松症 骨保护素 核因子κB受体活化子配体 resveratrol osteoporosis osteoprotegerin receptor activator of NF-κB ligand
  • 相关文献

参考文献10

  • 1Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: Anovelsecreted protein involved in the regulation of bone density[J]. Cell, 1997,89(2) :309 - 319.
  • 2Lacey DL,Timmes E,Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulats osteoclasts differentiation and activation[J]. Cell, 1998,93(2):165- 176.
  • 3苏欣,廖二元,朱旭萍,彭健.雌二醇对人成骨细胞护骨素、护骨素配体及其相关因子的调节[J].中华老年医学杂志,2004,23(3):153-156. 被引量:19
  • 4Greenfield EM, BI Y, Miyauchi A. Regulation of osteoclast activity[J]. Life Sei, 1999,65(11):1087- 1099.
  • 5肖本熙,黄忆明.白藜芦醇对去卵巢大鼠骨密度的影响[J].营养学报,2005,27(6):510-513. 被引量:7
  • 6刘兆平,于波,李文仙,孙静,黄建,霍军生,刘长兴.白藜芦醇的雌激素样作用研究[J].卫生研究,2002,31(3):188-190. 被引量:39
  • 7Bhat K,I.antvit D,Christov K, et al. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models[ J]. Cancer Res, 2001,61 (20) : 7456 - 7463.
  • 8朱鋐达.骨质疏松症的分子生物学进展[M]//罗敏.分子内分泌学.北京:人民军医出版社,2003:251-261.
  • 9Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenes-inhibitory factor and is identical to TRANCE/ RANKL[J]. Proc Nat Acad Sci USA, 1998,95(7):3597 - 3602.
  • 10Eghbah-Fatoumehi G, Khosla S, Sanyal A, et al. Role of rank hgand in mediating increased bone resorption in early postmenopausal women[ J]. J Clin Invest, 2003,111 (8) : 1120- 1122.

二级参考文献20

  • 1[1]Pace-Asciak CR, Hahn SE, Diamandis EP, et al. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta, 1995, 235: 207-219
  • 2[2]Sovak M. Grape extract, resveratrol and its analogs: a review. J Med Food, 2001, 4(2): 93-105
  • 3[3]Gehm BD, McAndrews JM, Cjien PY, et al. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA, 1997, 94: 14138-14143.
  • 4[4]Turner RT, Evans GL, Zhang M, et al. Is resveratrol an estrogen agonist in growing rats? Endocrinology, 1999, 140: 50-54
  • 5[5]Padilla-Banks E, Jefferson, Newbold RR. The immature mouse is a suitable model for detection of estrogenicity in the uterotropic bioassay. Environ Health Perspect, 2001, 109: 821-826.
  • 6[6]Anderson JJB, Garner SC. The effects of phytoestrogens on bone. Nutr Res, 1997, 17: 1617-1632
  • 7[7]Bertelli AAE, Giovannini L, Stradi R, et al. Kinetics of trans- and cis-resveratrol after red wine oral administration in rats. Int J Clin Pharmacol Res, 1996, 16: 77-81
  • 8Serrero G,Lu R.Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells[J].AntioxidRedox.Signal,2001,3:969-979.
  • 9宋丽华.[D].长沙:中南大学,2003.
  • 10Estrov Z,Shishodia S,Faderl S,et al.Resveratrol blocks interleukin-1 beta-induced activation of the nuclear transcription factor NF-kappa B,inhibits proliferation,causes S-phase arrest,and induces apoptosis of acute myeloid leukemia cells[J].Blood,2003,102:987-995.

共引文献62

同被引文献33

  • 1刘运荣,胡健华.植物多酚的研究进展[J].武汉工业学院学报,2005,24(4):63-65. 被引量:65
  • 2Muraki S,Yamamoto S,Ishibashi H.et al.Diet and lifestyle associated with increased bone mineral density:cross-sectional study of Japanese elderly women at an osteoporosis outpatient clinic[J].J Orthop Sci,2007,12(4):317-320.
  • 3Hegarty VM,May HM,Khaw KT.Tea drinking and bone mineral density in older women[J].The American Society for Clinical Nutrition,2000,71(4):1003-1007.
  • 4Shen CL,Wang P,Guerrieri J,et al.Protective effect of green tea polyphenols on bone loss in middle-aged female rats[J].Osteoporos Int,2008,19(7):979 -990.
  • 5Mount JG,Muzylak,Allen S,et al.Evidence that the canonical Wnt singnaling pathway regulates deer antler regeneration[J].Dev Dyn,2006,235(5):1390-1399.
  • 6Choi EM,Hwang JK.Effectcts of (+) -catechin on the fuction of osteoblastic cells[J].Biol Pharm Bull,2003,26(4):523 -526.
  • 7Yun JH,Kim CS,Cho KS,et al.(-)-Epigallocatechin gallate induces apoptosis,via caspase activation,in osteoclasts differentiation from RAW264.7 cells[J].Perioodontal Res,2007,42(3):212-218.
  • 8Schaefer S,Baum M,Eisenbrand G,et al.Modulation of oxidative cell damage by reconstituted mixtures of phenolic apple juice extracts in human colon cell lines[J].Mol Nutr Food Res,2006,50(4):413-417.
  • 9Wong RWK,Rabie ABM.Effect of Quercetin on Preosteoblasts and Bone Defects[J].The Open Orthopaedics Journal,2008,2 (1):27-32.
  • 10Prouilleta C,Mazie reb JC,Mazie reb C,et al.Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway[J].Biochem Pharmacol,2004,67(7):1307-1313.

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部